United States · 
Who invested in Indapta Therapeutics?
Indapta Therapeutics's investors include RA Capital Management, Vertex Ventures, Revent and Red Cedar Ventures.
United States · Venture startup
Who invested in Indapta Therapeutics
Funding summaryUpdated 26 Oct 2026
$51Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $51MOct 2025
- Investors
- 4
The rounds
- Oct 2025Venture$51M
Source recordedSEC filing: $51M sold, first sale Sept 2025
Founders and team
From Indapta Therapeutics's own website: 1 founder, 4 on the team.
Ronald MartellChairman of the Board and Co-Founder, Indapta
- Stefanie Mandl-CashmanActing Chief Scientific Officer
- Andrei ShustovHead of Clinical Development
- Linda BarnesHead of Regulatory & Quality
- Guy DiPierroTeam
Everyone who backed them
Red Cedar VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Indapta Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Indapta Therapeutics
How much has Indapta Therapeutics raised?
Indapta Therapeutics has raised $51M across 1 round since 2025.
When did Indapta Therapeutics last raise?
Indapta Therapeutics's most recent round was a Venture of $51M in Oct 2025.
What was Indapta Therapeutics's biggest round?
Its most recent round, $51M in Oct 2025, is also its largest on record.
Who backed Indapta Therapeutics first?
Indapta Therapeutics's first round on record, in Oct 2025, was backed by RA Capital Management, Vertex Ventures and Revent and 1 others.
What stage is Indapta Therapeutics at?
Indapta Therapeutics's latest named round is a Venture, in Oct 2025.
Where is Indapta Therapeutics based?
Indapta Therapeutics is based in the United States.
Companies like Indapta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.